Genetic Technologies logo

Genetic Technologies share price today

(GENE)

Genetic Technologies share price is $0.77 & ₹65.27 as on 17 Oct 2024, 2.30 'hrs' IST

$0.77

Market is closed - opens 8 PM, 16 Dec 2024

View live Genetic Technologies share price in Dollar and Rupees. Guide to invest in Genetic Technologies from India. Also see the sentimental analysis on Indian investors investing in Genetic Technologies. Get details on the Indian mutual funds that are investing in Genetic Technologies. Get Analyst recommendations and forecasts along with all the Genetic Technologies's financials.

Genetic Technologies Key Statistics

in dollars & INR

Previous Close
$0.765
Open
$0.79
Market Capitalization
$3.7M
Today's Volume
$22.7K
Revenue TTM
$9.7M
EBITDA
$-10.4M
Earnings Per Share (EPS)
$-0.02
Profit Margin
-124.24%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-184.98%

How to invest in Genetic Technologies from India?

It is very easy for Indian residents to invest directly in Genetic Technologies from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Genetic Technologies stock in both rupees (INR) and dollars (USD). Search for Genetic Technologies or GENE on INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Genetic Technologies or Rupee/ Dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Genetic Technologies shares which would translate to 1.101 fractional shares of Genetic Technologies as of today. Learn more about fractional investing here.

Indians via INDmoney can now also, easily transfer and add their money to the US stocks account via INDmoney App. Click here for step by step process for the same

Indian investors sentiment towards Genetic Technologies

39%

Period: Sep 14, 2024 to Dec 13, 2024. Change in 30 Days versus previous period

Search volume for Genetic Technologies on INDmoney from India has grown in the last 30 days as on Dec 14, 2024. 39% more investors are searching Genetic Technologies in the last 30 days versus the previous period.

Global Institutional Holdings in Genetic Technologies

  • Susquehanna International Group, LLP

    0.57%

  • Morgan Stanley - Brokerage Accounts

    0.40%

  • BNP Paribas Arbitrage, SA

    0.31%

  • TWO SIGMA SECURITIES, LLC

    0.30%

  • UBS Group AG

    0.18%

  • Rhumbline Advisers

    0.08%

Analyst Recommendation on Genetic Technologies

Analyst Forecast on Genetic Technologies

What analysts predicted

Upside of 1523.38%

Current:

$0.77

Target:

$12.50

Genetic Technologies Financials in INR & Dollars

FY19Y/Y Change
Revenue
$17.7K
↓ 86.56%
Net Income
$-4.7M
↑ 25.06%
Net Profit Margin
-26.9K%
↓ 23968.33%
FY20Y/Y Change
Revenue
$6.8K
↓ 61.23%
Net Income
$-4.3M
↓ 7.74%
Net Profit Margin
-63.9K%
↓ 37054.55%
FY21Y/Y Change
Revenue
$92.1K
↑ 1122.16%
Net Income
$-5.5M
↑ 14.34%
Net Profit Margin
-6.0K%
↑ 57930.93%
FY22Y/Y Change
Revenue
$4.8M
↑ 5536.33%
Net Income
$-5.0M
↓ 1.07%
Net Profit Margin
-104.95%
↑ 5874.06%
FY23Y/Y Change
Revenue
$7.0M
↑ 52.29%
Net Income
$-7.9M
↑ 64.79%
Net Profit Margin
-113.56%
↓ 8.61%
FY24Y/Y Change
Revenue
$5.1M
↓ 25.93%
Net Income
$-8.0M
↑ 2.27%
Net Profit Margin
-156.78%
↓ 43.22%
Q1 FY23Q/Q Change
Revenue
$1.8M
↓ 35.36%
Net Income
$-2.1M
↓ 42.4%
Net Profit Margin
-117.14%
↑ 14.31%
Q2 FY23Q/Q Change
Revenue
$3.0M
↑ 68.79%
Net Income
$-4.2M
↑ 100.0%
Net Profit Margin
-138.8%
↓ 21.66%
Q3 FY23Q/Q Change
Revenue
$2.4M
↓ 46.24%
Net Income
$-3.2M
↓ 48.98%
Net Profit Margin
-131.73%
↑ 7.07%
Q4 FY23Q/Q Change
Revenue
$4.0M
↑ 62.47%
Net Income
$-6.4M
↑ 100.0%
Net Profit Margin
-162.16%
↓ 30.43%
Q1 FY24Q/Q Change
Revenue
$2.4M
↓ 39.38%
Net Income
$-2.8M
↓ 56.4%
Net Profit Margin
-116.63%
↑ 45.53%
Q2 FY24Q/Q Change
Revenue
$4.8M
↑ 100.0%
Net Income
$-5.6M
↑ 100.0%
Net Profit Margin
-116.63%
↑ 0.0%
FY19Y/Y Change
Profit
$-174.3K
↑ 126.31%
FY20Y/Y Change
Profit
$-166.7K
↓ 3.66%
FY21Y/Y Change
Profit
$-183.7K
↓ 0.49%
FY22Y/Y Change
Profit
$4.6M
↓ 2792.02%
FY23Y/Y Change
Profit
$4.0M
↓ 7.12%
FY24Y/Y Change
Profit
$2.6M
↓ 35.06%
Q1 FY23Q/Q Change
Profit
$1.1M
↓ 202.9%
Q2 FY23Q/Q Change
Profit
$-821.9K
↓ 176.88%
Q3 FY23Q/Q Change
Profit
$1.6M
↓ 227.37%
Q4 FY23Q/Q Change
Profit
$-2.0M
↓ 227.14%
Q1 FY24Q/Q Change
Profit
$1.4M
↓ 170.56%
Q2 FY24Q/Q Change
Profit
$2.8M
↑ 100.0%
FY19Y/Y Change
Operating Cash Flow
$-4.2M
↑ 8.04%
Investing Cash Flow
$-364.4K
↓ 4186.81%
Financing Cash Flow
$2.2M
↓ 31477.72%
FY20Y/Y Change
Operating Cash Flow
$-3.9M
↓ 5.95%
Investing Cash Flow
$44.7K
↓ 112.35%
Financing Cash Flow
$12.7M
↑ 487.31%
FY21Y/Y Change
Operating Cash Flow
$-4.8M
↑ 10.22%
Investing Cash Flow
$-571.8K
↓ 1255.64%
Financing Cash Flow
$10.6M
↓ 24.05%
FY22Y/Y Change
Operating Cash Flow
$-4.0M
↓ 10.11%
Investing Cash Flow
$-2.4M
↑ 362.29%
Financing Cash Flow
$-196.2K
↓ 102.0%
FY23Y/Y Change
Operating Cash Flow
$-6.5M
↑ 71.8%
Investing Cash Flow
$-209.6K
↓ 90.99%
Financing Cash Flow
$4.0M
↓ 2221.36%
Q1 FY23Q/Q Change
Operating Cash Flow
$-687.4K
↓ 62.22%
Investing Cash Flow
$32.6K
↓ 123.83%
Financing Cash Flow
$4.2M
↓ 3896.16%
Q2 FY23Q/Q Change
Operating Cash Flow
$-1.8M
↑ 154.75%
Investing Cash Flow
$32.8K
↑ 0.0%
Financing Cash Flow
$-42.8K
↓ 101.01%

Genetic Technologies Technicals Summary

Sell

Neutral

Buy

Genetic Technologies is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Genetic Technologies Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin

About Genetic Technologies

genetic technologies (asx: gtg, nasdaq global market: gene) is leading-edge genetic testing and reproductive services business which, together with an extensive range of international patents and allied research activities, aims at uncovering the impact of dna on health. throughout the asia pacific region, we translate specialised genetic tests into products and services that optimise the health knowledge and outcomes in humans, animals and plants.
Organization
Genetic Technologies
Employees
55
CEO
Mr. Kevin Camilleri
Industry
Health Technology

Management People of Genetic Technologies

NameTitle
Mr. Kevin Camilleri
Chief Executive Officer of EasyDNA
Mr. Mark Ziirsen
CFO & Company Secretary
Mr. Paul Keith Mathieson Viney B. Bus, FCI, FCPA, FGIA
Consultant
Dr. Erika Spaeth Ph.D.
Director of Clinical & Scientific Affairs

Important FAQs about investing in Genetic Technologies from India :

What is Genetic Technologies share price today?

Genetic Technologies share price today stands at $0.77, Open: $0.79 ; Previous Close: $0.77 ; High: {{1_rba_end}} ; Low: {{1_rba_st}} ; 52 Week High: {{rba_end}} ; 52 Week Low: {{rba_st}}. The stock opens at $0.79, after a previous close of $0.77. The stock reached a daily high of {{1_rba_end}} and a low of {{1_rba_st}}, with a 52-week high of {{rba_end}} and a 52-week low of {{rba_st}}.

Can Indians buy Genetic Technologies shares?

Yes, Indians can invest in the Genetic Technologies (GENE) from India.

With INDmoney, you can buy Genetic Technologies at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Genetic Technologies at zero transaction cost.

How can I buy Genetic Technologies shares from India?

It is very easy to buy Genetic Technologies from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Genetic Technologies be purchased?

Yes, you can buy fractional shares of Genetic Technologies with INDmoney app.

What are the documents required to start investing in Genetic Technologies stocks?

To start investing in Genetic Technologies, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Genetic Technologies

Today’s highest price of Genetic Technologies (GENE) is {{1_rba_end}}.

Today’s lowest price of Genetic Technologies (GENE) is {{1_rba_st}}.

What is today's market capitalisation of Genetic Technologies

Today's market capitalisation of Genetic Technologies GENE is 3.7M

What is the 52 Week High and Low Range of Genetic Technologies

  • 52 Week High

    {{rba_end}}

  • 52 Week Low

    {{rba_st}}

How much percentage Genetic Technologies is down from its 52 Week High?

Genetic Technologies (GENE) share price is $0.77. It is down by 78.55% from its 52 Week High price of {{rba_end}}.

How much percentage Genetic Technologies is up from its 52 Week low?

Genetic Technologies (GENE) share price is $0.77. It is up by 15.51% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Genetic Technologies?

  • 1 Month Returns

    0%

  • 3 Months Returns

    -55%

  • 1 Year Returns

    -74.33%

  • 5 Years Returns

    -92.92%

Who is the Chief Executive Officer (CEO) of Genetic Technologies

Mr. Kevin Camilleri is the current Chief Executive Officer (CEO) of Genetic Technologies.